LEARNING OBJECTIVES :
Upon conclusion of this
meeting, participants will have increased ability to:
1. Recognize patients who are at high risk of developing CAD, atrial fibrillation or heart failure and how to approach diagnostic and therapeutic challenges.
2. Understand recently presented and published clinical trial results and how they can impact on clinical practice and management of patients with acute coronary syndromes, heart failure, and stable coronary artery disease.
3. Differentiate the mechanism of action in the management of disorders such as hypertension, dyslipidemia, diabetes, heart failure and arrhythmia through review of available agents.
4. Recognize the risks and benefits of various therapeutic options in managing patients with CAD.
5. Develop the most appropriate management strategy for patients with atrial fibrillation.
6. Appropriately implement results from recent trials of antiplatelet agents into clinical practice.
7. Recognize patients who are at high risk of developing CAD and match their risk to appropriate risk reducing strategies, including cholesterol reduction, glycemic control and BP control.
|
|
|
CARDIOLOGY FOR THE PRACTITIONER:
POINT-COUNTER POINT AND CONSENSUS
SATURDAY, APRIL 10, 2010
HILTON TORONTO HOTEL ~ 145 RICHMOND STREET WEST - VIEW MAP
|
07:30 |
REGISTRATION AND CONTINENTAL BREAKFAST |
|
| 08:30 |
WELCOME AND INTRODUCTION |
|
|
I - POINT-COUNTER POINT ON ATRIAL FIBRILLATION |
CHAIR:
DAVID FITCHETT, MD |
08:40 |
AF ABLATION: A 'GLASS SLIPPER'
OR 'ONE SIZE FITS ALL'? |
|
08:55 |
DO AS I SAY, NOT AS I DO:
A SNEAK PREVIEW OF AF GUIDELINES 2010 |
PAUL DORIAN, MD |
09:10 |
BEYOND COUMADIN: THE NEW FRONTIER |
|
09:25 |
CASE PRESENTATION /
PANEL DISCUSSION AND Q & A
WITH AUDIENCE RESPONSE SYSTEM |
|
10:00 |
NUTRITION BREAK |
|
|
II - CLINICAL TRIALS IN THE PAST YEAR THAT IMPACT ON MY PRACTICE |
|
10:30 |
AN UPDATE ON IMPORTANT STUDIES |
SHAUN GOODMAN, MD |
|
III - POINT-COUNTER POINT ON ANTIPLATELET THERAPY |
CHAIR:
ANDREW YAN, MD |
| 10:50 |
ASPIRIN IN DIABETES: RECOMMENDED BY GUIDELINES WITHOUT SUPPORT FROM DATA |
ANATOLY LANGER, MD |
11:05 |
LET'S GET PERSONAL: TAILORED THERAPY FOR CLOPIDOGREL RESISTANCE |
|
| 11:20 |
CONTINUALLY SHIFTING GOALPOSTS: THE FUTURE OF ANTI-PLATELET THERAPY |
JOHN GRAHAM, MD |
| 11:35 |
CASE PRESENTATION /
PANEL DISCUSSION AND Q & A
WITH AUDIENCE RESPONSE SYSTEM |
ALL FACULTY |
| 12:00 |
LUNCH |
|
| |
IV - INNOVATIONS IN CLINICAL PRACTICE |
CHAIR:
ABDUL AL HESAYEN,MD |
13:00 |
ECHO-DOPPLER SHOWS ELEVATED RVSP:
DOES MY PATIENT HAVE PULMONARY HYPERTENSION?
|
|
| 13:15 |
SQUEEZE THE KIDNEYS OR DILATE THE ARTERIES:
IS THERE A "CORRECT" COMBINATION TO LOWER BP? |
|
| 13:30 |
NEW 2009 CANADIAN LIPID GUIDELINES:
GO BIG OR GO HOME! |
BETH ABRAMSON, MD |
| 13:45 |
CASE PRESENTATION /
PANEL DISCUSSION AND Q & A
WITH AUDIENCE RESPONSE SYSTEM |
ALL FACULTY |
|
V - VALVULAR DISEASE IN YOUR PRACTICE:
AN EPIDEMIC OF 21ST CENTURY |
CHAIR:
MICHAEL FREEMAN, MD |
14:15 |
CAUGHT BETWEEN A ROCK AND A HARD PLACE:
COMPREHENSIVE ASSESSMENT OF AORTIC STENOSIS |
HOWARD LEONG-POI, MD
|
14:35 |
PERCUTANEOUS VALVE IMPLANTATION:
YOU'VE GOT TO BE KIDDING! |
|
14:55 |
CASE PRESENTATION /
PANEL DISCUSSION AND Q & A
WITH AUDIENCE RESPONSE SYSTEM |
|
| 15:25 |
THE GREAT CANADIAN CARDIOLOGY IDOL:
SO YOU THINK YOU KNOW CARDIOLOGY? |
ALL FACULTY |
15:50 |
EVALUATION AND ADJOURNMENT |
|
|
|
 |
This program meets the accreditation criteria of The College of Family Physicians of Canada and has been
accredited for up to 6 Mainpro-M1 credits.
This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification
program of The Royal College of Physicians and Surgeons of Canada, approved by the University of Toronto
(6 credits).
|
|
|
